In an era of increasingly bespoke healthcare, Elizabeth Philp has become a leading force of innovation, especially in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a drive to make bespoke medications more accessible,